U.S. Markets close in 1 hr 5 mins

Merck Snaps Up Cancer Drugmaker Peloton Therapeutics

Josh Nathan-Kazis

American pharmaceutical giant Merck & Co. said it is buying Peloton Therapeutics, a clinical-stage biopharmaceutical company, for $1.05 billion in cash.